// App-Quantinova.ai

: RATE OF THROMBOSIS IN CONTEMPORARY PATIENTS WITH POLYCYTHEMIA VERA UNDER HYDROXYUREA REMAINS EXCEEDINGLY HIGH. RESULTS OF SYSTEMATIC REVIEW AND METANALYSIS.

Researchers

Presenter

  • Alberto Ferrari

Principal Investigators

  • Alessandra Carobbio

  • Arianna Masciulli

  • Arianna Ghirardi

  • Guido Finazzi

  • Valerio De Stefano

  • Alessandro Maria Vannucchi

  • Tiziano Barbui

Medical Centers

  • FROM research foundation,Bergamo,Italy

  • Rheumatology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy

  • Institute of Hematology, Catholic University, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

  • CRIMM-Center of Research and Innovation of Myeloproliferative Neoplasms,Azienda Ospedaliero-Universitaria Careggi,Florence,Italy;Department of Experimental and Clinical Medicine,University of Florence,Florence,Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A